Achievements in therapy of atherosclerosis
Abstract
Atherosclerosis is the main reason of high morbidity and mortality in the world. To date, numerous studies of medicines which decrease mortality due to cardiovascular diseases (CVD) and/or facilitate regression of atherosclerotic lesions have been conducted. Parameters assessed in the clinical studies are total mortality, mortality due to CVD and myocardial infarction risk. Using a few biomarkers, new drugs efficiency can be tested quickly and comprehensively. Therapy with statins targeted to low density lipoprotein metaboiism was shown to promote atherosclerosis regression. A group of new drugs affecting high density lipoprotein metabolism or inflammatory and oxidative processes are currently under investigation and believed to be effective in atherosclerosis regression. This paper reviews studies on the newest anti-atherosclerotic drugs with cutting-edge imaging methods used to estimate atherosclerosis severity.